ID;Description;GeneRatio;BgRatio;pvalue;p.adjust;qvalue;geneID;Count
GO:0002020;protease binding;9/135;135/18368;6,84215060685867e-07;0,000313370497794127;0,000254239912023275;PARK7/PINK1/POLG/PRKN/PTEN/PZP/SLC2A13/SLC6A3/TWNK;9
GO:0051087;chaperone binding;7/135;107/18368;1,40264752631856e-05;0,002932624748102093;0,002379261172328289;ATP1A3/CLU/CP/GAK/GRN/MAPT/PRKN;7
GO:0048156;tau protein binding;5/135;45/18368;1,92093324111491e-05;0,002932624748102093;0,002379261172328289;APOE/CLU/DCTN1/PICALM/SNCA;5
GO:0004175;endopeptidase activity;12/135;430/18368;8,01599657408797e-05;0,009178316077330726;0,007446438922771192;ATG4C/CPS1/HTRA2/LPA/PRSS48/PSEN1/SPG7/SPPL2C/UCHL1/USP20/USP24/USP40;12
GO:1901338;catecholamine binding;3/135;13/18368;1,05220553220501e-04;0,009638202674997870;0,007819548481439320;DRD4/SLC6A3/TH;3
GO:1990381;ubiquitin-specific protease binding;3/135;21/18368;4,68692482381381e-04;0,035776859488445389;0,029026043207127612;PARK7/PRKN/PTEN;3
GO:0050750;low-density lipoprotein particle receptor binding;3/135;23/18368;6,17430414720871e-04;0,040181224593588756;0,032599338730261621;APOE/CLU/PICALM;3
GO:0043274;phospholipase binding;3/135;24/18368;7,01855451416397e-04;0,040181224593588756;0,032599338730261621;DGKQ/PRKN/SNCA;3
GO:0005507;copper ion binding;4/135;61/18368;1,05300228368229e-03;0,050924306080673741;0,041315283949615790;ATP13A2/CP/PARK7/SNCA;4
GO:0070325;lipoprotein particle receptor binding;3/135;28/18368;1,11188441224178e-03;0,050924306080673741;0,041315283949615790;APOE/CLU/PICALM;3
GO:0046873;metal ion transmembrane transporter activity;10/135;430/18368;1,30193990799033e-03;0,054208043441779007;0,043979405504362190;ATP1A3/ITPR1/KCNK16/PKD2/PSEN1/SCN3A/SLC18A2/SLC30A10/SLC6A3/TMEM175;10
GO:0031625;ubiquitin protein ligase binding;8/135;297/18368;1,60116588834971e-03;0,061111164738680508;0,049579961279600591;CLU/FBXO7/PINK1/PRKN/TNK2/UCHL1/UQCRC1/WFS1;8
GO:0004197;cysteine-type endopeptidase activity;5/135;119/18368;1,86164341509453e-03;0,063819078063780690;0,051776912333979734;ATG4C/UCHL1/USP20/USP24/USP40;5
GO:0030276;clathrin binding;4/135;72/18368;1,95080151286666e-03;0,063819078063780690;0,051776912333979734;DNAJC6/GAK/LRRK2/PICALM;4
GO:0044389;ubiquitin-like protein ligase binding;8/135;316/18368;2,35592292743743e-03;0,071934180051089605;0,058360757430555334;CLU/FBXO7/PINK1/PRKN/TNK2/UCHL1/UQCRC1/WFS1;8
GO:0017124;SH3 domain binding;5/135;130/18368;2,73678457874069e-03;0,076075534817805338;0,061720670629016969;DNAJC6/DRD4/MAPT/PRKN/SYNJ1;5
GO:0015378;sodium:chloride symporter activity;2/135;11/18368;2,82376439280063e-03;0,076075534817805338;0,061720670629016969;SLC18A2/SLC6A3;2
GO:0001540;amyloid-beta binding;4/135;84/18368;3,41947356177323e-03;0,082427310068007298;0,066873915086202204;APOE/ATP1A3/CLU/PICALM;4
GO:0030165;PDZ domain binding;4/135;84/18368;3,41947356177323e-03;0,082427310068007298;0,066873915086202204;GRID2/PRKN/PSEN1/PTEN;4
GO:0022853;active ion transmembrane transporter activity;7/135;267/18368;3,62238337607808e-03;0,082952579312188052;0,067300070092398023;ATP13A2/ATP1A3/SLC18A2/SLC2A13/SLC45A3/SLC6A3/UQCRC1;7
GO:0016887;ATP hydrolysis activity;7/135;272/18368;4,00852190675695e-03;0,087423953966413573;0,070927730981714524;ATP10B/ATP13A2/ATP1A3/GET3/KIF21A/SMARCAD1/TWNK;7
GO:0051117;ATPase binding;4/135;89/18368;4,20705746878404e-03;0,087583287304685981;0,071056999353146758;PKD2/PSEN1/SLC2A13/WFS1;4
GO:0015373;anion:sodium symporter activity;2/135;14/18368;4,60508731980388e-03;0,090340348754230679;0,073293824661556942;SLC18A2/SLC6A3;2
GO:0043130;ubiquitin binding;4/135;92/18368;4,73399207445750e-03;0,090340348754230679;0,073293824661556942;FBXO7/PRKN/SMARCAD1/UCHL1;4
GO:0015081;sodium ion transmembrane transporter activity;5/135;152/18368;5,32382459514747e-03;0,097532466583101649;0,079128845561560288;ATP1A3/PKD2/SCN3A/SLC18A2/SLC6A3;5
GO:0000287;magnesium ion binding;6/135;221/18368;5,88741720089507e-03;0,099576127829985275;0,080786883760020231;ATP10B/COMT/LRRK2/MAP3K6/PINK1/SNCA;6
GO:0022841;potassium ion leak channel activity;2/135;16/18368;6,01456513936060e-03;0,099576127829985275;0,080786883760020231;KCNK16/TMEM175;2
GO:0015278;calcium-release channel activity;2/135;17/18368;6,78386138267362e-03;0,099576127829985275;0,080786883760020231;ITPR1/PKD2;2
GO:0015377;cation:chloride symporter activity;2/135;17/18368;6,78386138267362e-03;0,099576127829985275;0,080786883760020231;SLC18A2/SLC6A3;2
GO:0034185;apolipoprotein binding;2/135;17/18368;6,78386138267362e-03;0,099576127829985275;0,080786883760020231;LPA/MAPT;2
GO:0052745;inositol phosphate phosphatase activity;2/135;17/18368;6,78386138267362e-03;0,099576127829985275;0,080786883760020231;PTEN/SYNJ1;2
GO:1901618;organic hydroxy compound transmembrane transporter activity;3/135;53/18368;6,95728404052299e-03;0,099576127829985275;0,080786883760020231;SLC18A2/SLC2A13/SLC6A3;3
GO:0015294;solute:cation symporter activity;4/135;104/18368;7,28315518295040e-03;0,101081365872463164;0,082008095042471835;SLC18A2/SLC2A13/SLC45A3/SLC6A3;4
GO:0004438;phosphatidylinositol-3-phosphatase activity;2/135;18/18368;7,59531464929228e-03;0,101823923390074969;0,082610537707875117;PTEN/SYNJ1;2
GO:1902936;phosphatidylinositol bisphosphate binding;4/135;107/18368;8,03790676191560e-03;0,101823923390074969;0,082610537707875117;ATP13A2/MAPT/PICALM/WDR45;4
GO:0022840;leak channel activity;2/135;19/18368;8,44827311970054e-03;0,101823923390074969;0,082610537707875117;KCNK16/TMEM175;2
GO:0022842;narrow pore channel activity;2/135;19/18368;8,44827311970054e-03;0,101823923390074969;0,082610537707875117;KCNK16/TMEM175;2
GO:0052744;phosphatidylinositol monophosphate phosphatase activity;2/135;19/18368;8,44827311970054e-03;0,101823923390074969;0,082610537707875117;PTEN/SYNJ1;2
GO:0032182;ubiquitin-like protein binding;4/135;111/18368;9,12169669592674e-03;0,106409287583618145;0,086330679193328444;FBXO7/PRKN/SMARCAD1/UCHL1;4
GO:0004721;phosphoprotein phosphatase activity;5/135;174/18368;9,29338756188805e-03;0,106409287583618145;0,086330679193328444;DNAJC6/LRRK2/PPM1K/PTEN/PTPRH;5
GO:0004843;thiol-dependent deubiquitinase;4/135;113/18368;9,69761242651056e-03;0,108329426618093569;0,087888502864139351;UCHL1/USP20/USP24/USP40;4
GO:0101005;deubiquitinase activity;4/135;114/18368;9,99423026906215e-03;0,108984701505487280;0,088420132455612518;UCHL1/USP20/USP24/USP40;4
GO:0022804;active transmembrane transporter activity;8/135;406/18368;1,03395865109066e-02;0,110128619116168239;0,089348201673195571;ABCG2/ATP13A2/ATP1A3/SLC18A2/SLC2A13/SLC45A3/SLC6A3/UQCRC1;8
GO:0015296;anion:cation symporter activity;2/135;22/18368;1,12497688461585e-02;0,114497647367569164;0,092892828133192162;SLC18A2/SLC6A3;2
GO:0120020;cholesterol transfer activity;2/135;22/18368;1,12497688461585e-02;0,114497647367569164;0,092892828133192162;APOE/GRAMD1C;2
GO:0005248;voltage-gated sodium channel activity;2/135;23/18368;1,22623725062955e-02;0,119492906550708988;0,096945520598483742;PKD2/SCN3A;2
GO:0120015;sterol transfer activity;2/135;23/18368;1,22623725062955e-02;0,119492906550708988;0,096945520598483742;APOE/GRAMD1C;2
GO:0008234;cysteine-type peptidase activity;5/135;190/18368;1,32213343789783e-02;0,123292474861817450;0,100028139798256865;ATG4C/UCHL1/USP20/USP24/USP40;5
GO:0015295;solute:proton symporter activity;2/135;24/18368;1,33133286021936e-02;0,123292474861817450;0,100028139798256865;SLC2A13/SLC45A3;2
GO:0019783;ubiquitin-like protein-specific protease activity;4/135;125/18368;1,36507425872024e-02;0,123292474861817450;0,100028139798256865;UCHL1/USP20/USP24/USP40;4
GO:0008242;omega peptidase activity;4/135;126/18368;1,40199477898721e-02;0,123292474861817450;0,100028139798256865;UCHL1/USP20/USP24/USP40;4
GO:0008017;microtubule binding;6/135;271/18368;1,50986068881392e-02;0,123292474861817450;0,100028139798256865;DCTN1/KIF21A/LRRK2/MAPT/SNCA/VAPB;6
GO:0016298;lipase activity;4/135;129/18368;1,51654312190126e-02;0,123292474861817450;0,100028139798256865;CEL/LIPI/PLA2G6/SMPD1;4
GO:0031072;heat shock protein binding;4/135;129/18368;1,51654312190126e-02;0,123292474861817450;0,100028139798256865;ADORA1/MAPT/PRKN/SNCA;4
GO:0004806;triglyceride lipase activity;2/135;26/18368;1,55278658262321e-02;0,123292474861817450;0,100028139798256865;CEL/LIPI;2
GO:0008198;ferrous iron binding;2/135;26/18368;1,55278658262321e-02;0,123292474861817450;0,100028139798256865;SNCA/TH;2
GO:0099604;ligand-gated calcium channel activity;2/135;26/18368;1,55278658262321e-02;0,123292474861817450;0,100028139798256865;ITPR1/PKD2;2
GO:0016791;phosphatase activity;6/135;275/18368;1,61164840053646e-02;0,123292474861817450;0,100028139798256865;DNAJC6/LRRK2/PPM1K/PTEN/PTPRH/SYNJ1;6
GO:0004190;aspartic-type endopeptidase activity;2/135;27/18368;1,66902476887176e-02;0,123292474861817450;0,100028139798256865;PSEN1/SPPL2C;2
GO:0004709;MAP kinase kinase kinase activity;2/135;27/18368;1,66902476887176e-02;0,123292474861817450;0,100028139798256865;LRRK2/MAP3K6;2
GO:0034593;phosphatidylinositol bisphosphate phosphatase activity;2/135;27/18368;1,66902476887176e-02;0,123292474861817450;0,100028139798256865;PTEN/SYNJ1;2
GO:0051119;sugar transmembrane transporter activity;2/135;27/18368;1,66902476887176e-02;0,123292474861817450;0,100028139798256865;SLC45A3/SLC50A1;2
GO:0070001;aspartic-type peptidase activity;2/135;28/18368;1,78885833253696e-02;0,128015174422176359;0,103859702530517697;PSEN1/SPPL2C;2
GO:0080025;phosphatidylinositol-3,5-bisphosphate binding;2/135;28/18368;1,78885833253696e-02;0,128015174422176359;0,103859702530517697;ATP13A2/WDR45;2
GO:0042578;phosphoric ester hydrolase activity;7/135;366/18368;1,86158769118861e-02;0,131170332702212705;0,106419506880903431;DNAJC6/LRRK2/PPM1K/PTEN/PTPRH/SMPD1/SYNJ1;7
GO:0005217;intracellular ligand-gated ion channel activity;2/135;30/18368;2,03907902255037e-02;0,139458024319099899;0,113143375280722269;ITPR1/PKD2;2
GO:0015631;tubulin binding;7/135;375/18368;2,09450039936609e-02;0,139458024319099899;0,113143375280722269;DCTN1/KIF21A/LRRK2/MAPT/PRKN/SNCA/VAPB;7
GO:0071813;lipoprotein particle binding;2/135;31/18368;2,16935148696981e-02;0,139458024319099899;0,113143375280722269;APOE/MAPT;2
GO:0071814;protein-lipid complex binding;2/135;31/18368;2,16935148696981e-02;0,139458024319099899;0,113143375280722269;APOE/MAPT;2
GO:0015293;symporter activity;4/135;144/18368;2,17709132656815e-02;0,139458024319099899;0,113143375280722269;SLC18A2/SLC2A13/SLC45A3/SLC6A3;4
GO:0005543;phospholipid binding;8/135;466/18368;2,18863507050428e-02;0,139458024319099899;0,113143375280722269;APOE/ATP13A2/CPS1/ITPR1/MAPT/PICALM/SNCA/WDR45;8
GO:0001664;G protein-coupled receptor binding;6/135;295/18368;2,19235322073694e-02;0,139458024319099899;0,113143375280722269;ADORA1/POMC/PRKN/UCHL1/USP20/VPS35;6
GO:0051721;protein phosphatase 2A binding;2/135;32/18368;2,30298999237970e-02;0,144038784006225717;0,116859781094455703;MAPT/SLC6A3;2
GO:0052689;carboxylic ester hydrolase activity;4/135;147/18368;2,32726419573378e-02;0,144038784006225717;0,116859781094455703;CEL/LIPI/PLA2G6/PTRHD1;4
GO:0031369;translation initiation factor binding;2/135;33/18368;2,43993880248927e-02;0,148998929538677827;0,120883985582976972;EIF4G1/GCH1;2
GO:0052866;phosphatidylinositol phosphate phosphatase activity;2/135;34/18368;2,58014280776141e-02;0,155487553415095736;0,126148256390551133;PTEN/SYNJ1;2
GO:0015079;potassium ion transmembrane transporter activity;4/135;155/18368;2,75797972830967e-02;0,164046066956601122;0,133091844715422153;ATP1A3/KCNK16/PKD2/TMEM175;4
GO:0015248;sterol transporter activity;2/135;36/18368;2,87009906293142e-02;0,168526329592639523;0,136726716493223988;APOE/GRAMD1C;2
GO:0044390;ubiquitin-like protein conjugating enzyme binding;2/135;38/18368;3,17243018662922e-02;0,183920636136225585;0,149216236626264376;PARK7/PRKN;2
GO:0015291;secondary active transmembrane transporter activity;5/135;240/18368;3,22817977767902e-02;0,184813292272123980;0,149940455463249300;ATP1A3/SLC18A2/SLC2A13/SLC45A3/SLC6A3;5
GO:0019825;oxygen binding;2/135;39/18368;3,32810503782072e-02;0,187624648637500890;0,152221330657407089;PARK7/TH;2
GO:0016874;ligase activity;4/135;165/18368;3,35921860006006e-02;0,187624648637500890;0,152221330657407089;CPS1/DARS1/MCCC1/UCHL1;4
GO:0008201;heparin binding;4/135;166/18368;3,42322318025077e-02;0,188895929705403975;0,153252730834308432;APOE/CEL/LIPI/LPA;4
GO:0015144;carbohydrate transmembrane transporter activity;2/135;40/18368;3,48671725156733e-02;0,189873056779895050;0,154045481598030221;SLC45A3/SLC50A1;2
GO:0004722;protein serine/threonine phosphatase activity;3/135;98/18368;3,56278908552657e-02;0,189873056779895050;0,154045481598030221;LRRK2/PPM1K/PTEN;3
GO:0045296;cadherin binding;6/135;332/18368;3,60972516108716e-02;0,189873056779895050;0,154045481598030221;GIGYF2/PARK7/PICALM/PSEN1/PTPRH/VAPB;6
GO:0030020;extracellular matrix structural constituent conferring tensile strength;2/135;41/18368;3,64821593812899e-02;0,189873056779895050;0,154045481598030221;COL15A1/COL6A5;2
GO:0048487;beta-tubulin binding;2/135;41/18368;3,64821593812899e-02;0,189873056779895050;0,154045481598030221;SNCA/VAPB;2
GO:0005261;cation channel activity;6/135;335/18368;3,74547993860318e-02;0,192744922683174946;0,156375448648956028;ITPR1/KCNK16/PKD2/PSEN1/SCN3A/TMEM175;6
GO:0005201;extracellular matrix structural constituent;4/135;172/18368;3,82215641918850e-02;0,194505293332037171;0,157803650991057504;COL15A1/COL6A5/MMRN1/OGN;4
GO:1901981;phosphatidylinositol phosphate binding;4/135;173/18368;3,89113385303596e-02;0,195839484031919669;0,158886090239640648;ATP13A2/MAPT/PICALM/WDR45;4
GO:0004725;protein tyrosine phosphatase activity;3/135;102/18368;3,93879834198227e-02;0,195988151048667958;0,159006704941805993;DNAJC6/PTEN/PTPRH;3
GO:0030544;Hsp70 protein binding;2/135;43/18368;3,97967206277863e-02;0,195988151048667958;0,159006704941805993;PRKN/SNCA;2
GO:0005216;ion channel activity;7/135;432/18368;4,05259285054042e-02;0,197456119739097130;0,160197679310276425;GRID2/ITPR1/KCNK16/PKD2/PSEN1/SCN3A/TMEM175;7
GO:0004620;phospholipase activity;3/135;104/18368;4,13407830108487e-02;0,199306090725986373;0,161698575100604897;LIPI/PLA2G6/SMPD1;3
GO:0015399;primary active transmembrane transporter activity;4/135;181/18368;4,46858775925844e-02;0,212345116808017598;0,172277237952723983;ABCG2/ATP13A2/ATP1A3/UQCRC1;4
GO:0005272;sodium channel activity;2/135;46/18368;4,49726557431828e-02;0,212345116808017598;0,172277237952723983;PKD2/SCN3A;2
GO:1901681;sulfur compound binding;5/135;265/18368;4,61408028695079e-02;0,213823180516505451;0,173476402487534848;APOE/CEL/LIPI/LPA/MCCC1;5
GO:0042626;ATPase-coupled transmembrane transporter activity;3/135;109/18368;4,64324532480979e-02;0,213823180516505451;0,173476402487534848;ABCG2/ATP13A2/ATP1A3;3
GO:0019829;ATPase-coupled cation transmembrane transporter activity;2/135;47/18368;4,67504647381084e-02;0,213823180516505451;0,173476402487534848;ATP13A2/ATP1A3;2
GO:0000149;SNARE binding;3/135;110/18368;4,74863824597929e-02;0,213823180516505451;0,173476402487534848;LRRK2/PICALM/SNCA;3
GO:0030594;neurotransmitter receptor activity;3/135;111/18368;4,85520681754559e-02;0,213823180516505451;0,173476402487534848;ADORA1/DRD4/GRID2;3
GO:0016879;ligase activity, forming carbon-nitrogen bonds;2/135;48/18368;4,85537353137916e-02;0,213823180516505451;0,173476402487534848;CPS1/MCCC1;2
GO:0120013;lipid transfer activity;2/135;48/18368;4,85537353137916e-02;0,213823180516505451;0,173476402487534848;APOE/GRAMD1C;2
GO:0035091;phosphatidylinositol binding;5/135;271/18368;4,99217302961336e-02;0,216226654150490666;0,175426359262521703;ATP13A2/ITPR1/MAPT/PICALM/WDR45;5
GO:0106310;protein serine kinase activity;6/135;360/18368;5,00437234496769e-02;0,216226654150490666;0,175426359262521703;GAK/KALRN/LRRK2/MAP3K6/PINK1/TNK2;6
GO:0140359;ABC-type transporter activity;2/135;50/18368;5,22348101950528e-02;0,223584514666674727;0,181395848488476646;ABCG2/ATP13A2;2
GO:0017171;serine hydrolase activity;4/135;195/18368;5,58853087921961e-02;0,235354147493471916;0,190944642760734501;HTRA2/LPA/PLA2G6/PRSS48;4
GO:0016597;amino acid binding;2/135;52/18368;5,60122316087084e-02;0,235354147493471916;0,190944642760734501;CPS1/TH;2
GO:0005262;calcium channel activity;3/135;119/18368;5,74946590824186e-02;0,239386853270433630;0,194216408192284667;ITPR1/PKD2/PSEN1;3
GO:0005267;potassium channel activity;3/135;121/18368;5,98441738103665e-02;0,244876385169094768;0,198670107939991847;KCNK16/PKD2/TMEM175;3
GO:0008408;3'-5' exonuclease activity;2/135;54/18368;5,98824348011760e-02;0,244876385169094768;0,198670107939991847;DIS3/POLG;2
GO:0051082;unfolded protein binding;3/135;122/18368;6,10356946497344e-02;0,247383611943171433;0,200704240441138854;CLU/HTRA2/SPG7;3
GO:0015267;channel activity;7/135;480/18368;6,41756349364261e-02;0,257828428077922500;0,209178200669976194;GRID2/ITPR1/KCNK16/PKD2/PSEN1/SCN3A/TMEM175;7
GO:0022803;passive transmembrane transporter activity;7/135;481/18368;6,47421024435856e-02;0,257842460166627874;0,209189585012226176;GRID2/ITPR1/KCNK16/PKD2/PSEN1/SCN3A/TMEM175;7
GO:0015078;proton transmembrane transporter activity;3/135;130/18368;7,09619972643172e-02;0,258553495864683236;0,209766453781275980;SLC2A13/SLC45A3/UQCRC1;3
GO:0004465;lipoprotein lipase activity;1/135;10/18368;7,11304377269653e-02;0,258553495864683236;0,209766453781275980;LIPI;1
GO:0005384;manganese ion transmembrane transporter activity;1/135;10/18368;7,11304377269653e-02;0,258553495864683236;0,209766453781275980;SLC30A10;1
GO:0008190;eukaryotic initiation factor 4E binding;1/135;10/18368;7,11304377269653e-02;0,258553495864683236;0,209766453781275980;EIF4G1;1
GO:0016595;glutamate binding;1/135;10/18368;7,11304377269653e-02;0,258553495864683236;0,209766453781275980;CPS1;1
GO:0016884;carbon-nitrogen ligase activity, with glutamine as amido-N-donor;1/135;10/18368;7,11304377269653e-02;0,258553495864683236;0,209766453781275980;CPS1;1
GO:0018455;alcohol dehydrogenase [NAD(P)+] activity;1/135;10/18368;7,11304377269653e-02;0,258553495864683236;0,209766453781275980;ADH1C;1
GO:0034596;phosphatidylinositol phosphate 4-phosphatase activity;1/135;10/18368;7,11304377269653e-02;0,258553495864683236;0,209766453781275980;SYNJ1;1
GO:0036312;phosphatidylinositol 3-kinase regulatory subunit binding;1/135;10/18368;7,11304377269653e-02;0,258553495864683236;0,209766453781275980;FAM83A;1
GO:0043139;5'-3' DNA helicase activity;1/135;10/18368;7,11304377269653e-02;0,258553495864683236;0,209766453781275980;TWNK;1
GO:0046030;inositol trisphosphate phosphatase activity;1/135;10/18368;7,11304377269653e-02;0,258553495864683236;0,209766453781275980;SYNJ1;1
GO:0098960;postsynaptic neurotransmitter receptor activity;2/135;62/18368;7,62226196651882e-02;0,260629095749306261;0,211450404043909690;DRD4/GRID2;2
GO:0015085;calcium ion transmembrane transporter activity;3/135;135/18368;7,75118470630210e-02;0,260629095749306261;0,211450404043909690;ITPR1/PKD2/PSEN1;3
GO:0043177;organic acid binding;3/135;135/18368;7,75118470630210e-02;0,260629095749306261;0,211450404043909690;CPS1/MCCC1/TH;3
GO:0004143;diacylglycerol kinase activity;1/135;11/18368;7,79611050603820e-02;0,260629095749306261;0,211450404043909690;DGKQ;1
GO:0008199;ferric iron binding;1/135;11/18368;7,79611050603820e-02;0,260629095749306261;0,211450404043909690;TH;1
GO:0016273;arginine N-methyltransferase activity;1/135;11/18368;7,79611050603820e-02;0,260629095749306261;0,211450404043909690;PRMT3;1
GO:0016274;protein-arginine N-methyltransferase activity;1/135;11/18368;7,79611050603820e-02;0,260629095749306261;0,211450404043909690;PRMT3;1
GO:0019855;calcium channel inhibitor activity;1/135;11/18368;7,79611050603820e-02;0,260629095749306261;0,211450404043909690;ITPR1;1
GO:0052629;phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity;1/135;11/18368;7,79611050603820e-02;0,260629095749306261;0,211450404043909690;SYNJ1;1
GO:0097157;pre-mRNA intronic binding;1/135;11/18368;7,79611050603820e-02;0,260629095749306261;0,211450404043909690;TARDBP;1
GO:0102545;phosphatidyl phospholipase B activity;1/135;11/18368;7,79611050603820e-02;0,260629095749306261;0,211450404043909690;PLA2G6;1
GO:0030145;manganese ion binding;2/135;65/18368;8,26754123530682e-02;0,265314874052716143;0,215252012274439880;ATP13A2/GALNT3;2
GO:0004875;complement receptor activity;1/135;12/18368;8,47419107920835e-02;0,265314874052716143;0,215252012274439880;CR1;1
GO:0005095;GTPase inhibitor activity;1/135;12/18368;8,47419107920835e-02;0,265314874052716143;0,215252012274439880;TNK2;1
GO:0015166;polyol transmembrane transporter activity;1/135;12/18368;8,47419107920835e-02;0,265314874052716143;0,215252012274439880;SLC2A13;1
GO:0033130;acetylcholine receptor binding;1/135;12/18368;8,47419107920835e-02;0,265314874052716143;0,215252012274439880;RIC3;1
GO:0034452;dynactin binding;1/135;12/18368;8,47419107920835e-02;0,265314874052716143;0,215252012274439880;MAPT;1
GO:0043422;protein kinase B binding;1/135;12/18368;8,47419107920835e-02;0,265314874052716143;0,215252012274439880;PINK1;1
GO:0070851;growth factor receptor binding;3/135;141/18368;8,57084928365309e-02;0,265314874052716143;0,215252012274439880;PSEN1/PTEN/TNK2;3
GO:0097110;scaffold protein binding;2/135;67/18368;8,70673440983624e-02;0,265314874052716143;0,215252012274439880;GRID2/PARK7;2
GO:0015276;ligand-gated ion channel activity;3/135;143/18368;8,85198589726239e-02;0,265314874052716143;0,215252012274439880;GRID2/ITPR1/PKD2;3
GO:0022834;ligand-gated channel activity;3/135;143/18368;8,85198589726239e-02;0,265314874052716143;0,215252012274439880;GRID2/ITPR1/PKD2;3
GO:0005539;glycosaminoglycan binding;4/135;230/18368;8,98131905997628e-02;0,265314874052716143;0,215252012274439880;APOE/CEL/LIPI/LPA;4
GO:0061134;peptidase regulator activity;4/135;230/18368;8,98131905997628e-02;0,265314874052716143;0,215252012274439880;LPA/PINK1/PZP/SNCA;4
GO:0015271;outward rectifier potassium channel activity;1/135;13/18368;9,14732161986578e-02;0,265314874052716143;0,215252012274439880;PKD2;1
GO:0034595;phosphatidylinositol phosphate 5-phosphatase activity;1/135;13/18368;9,14732161986578e-02;0,265314874052716143;0,215252012274439880;SYNJ1;1
GO:0039706;co-receptor binding;1/135;13/18368;9,14732161986578e-02;0,265314874052716143;0,215252012274439880;LRRK2;1
GO:0070679;inositol 1,4,5 trisphosphate binding;1/135;13/18368;9,14732161986578e-02;0,265314874052716143;0,215252012274439880;ITPR1;1
GO:0106019;phosphatidylinositol-4,5-bisphosphate phosphatase activity;1/135;13/18368;9,14732161986578e-02;0,265314874052716143;0,215252012274439880;SYNJ1;1
GO:0140299;small molecule sensor activity;1/135;13/18368;9,14732161986578e-02;0,265314874052716143;0,215252012274439880;PARK7;1
GO:0140333;glycerophospholipid flippase activity;1/135;13/18368;9,14732161986578e-02;0,265314874052716143;0,215252012274439880;ATP10B;1
GO:0003777;microtubule motor activity;2/135;69/18368;9,15278386470069e-02;0,265314874052716143;0,215252012274439880;DNAH8/KIF21A;2
GO:0015562;efflux transmembrane transporter activity;1/135;14/18368;9,81553799585689e-02;0,272688927512410251;0,221234638960884411;ABCG2;1
GO:0102991;myristoyl-CoA hydrolase activity;1/135;14/18368;9,81553799585689e-02;0,272688927512410251;0,221234638960884411;PLA2G6;1
GO:0106018;phosphatidylinositol-3,5-bisphosphate phosphatase activity;1/135;14/18368;9,81553799585689e-02;0,272688927512410251;0,221234638960884411;SYNJ1;1
GO:0003678;DNA helicase activity;2/135;72/18368;9,83407799939403e-02;0,272688927512410251;0,221234638960884411;SMARCAD1/TWNK;2
GO:0004842;ubiquitin-protein transferase activity;6/135;433/18368;1,00197710285701e-01;0,272688927512410251;0,221234638960884411;FBXO7/HERC3/HERC5/HERC6/PRKN/RFPL2;6
GO:0015370;solute:sodium symporter activity;2/135;73/18368;1,00642928931011e-01;0,272688927512410251;0,221234638960884411;SLC18A2/SLC6A3;2
GO:0106306;protein serine phosphatase activity;2/135;73/18368;1,00642928931011e-01;0,272688927512410251;0,221234638960884411;PPM1K/PTEN;2
GO:0106307;protein threonine phosphatase activity;2/135;73/18368;1,00642928931011e-01;0,272688927512410251;0,221234638960884411;PPM1K/PTEN;2
GO:0140104;molecular carrier activity;2/135;73/18368;1,00642928931011e-01;0,272688927512410251;0,221234638960884411;CLU/PARK7;2
GO:0015103;inorganic anion transmembrane transporter activity;3/135;152/18368;1,01639706427868e-01;0,272688927512410251;0,221234638960884411;GET3/SLC18A2/SLC6A3;3
GO:0005319;lipid transporter activity;3/135;154/18368;1,04655711492562e-01;0,272688927512410251;0,221234638960884411;APOE/ATP10B/GRAMD1C;3
GO:0001846;opsonin binding;1/135;15/18368;1,04788758170708e-01;0,272688927512410251;0,221234638960884411;CR1;1
GO:0005041;low-density lipoprotein particle receptor activity;1/135;15/18368;1,04788758170708e-01;0,272688927512410251;0,221234638960884411;LRP10;1
GO:0005161;platelet-derived growth factor receptor binding;1/135;15/18368;1,04788758170708e-01;0,272688927512410251;0,221234638960884411;PTEN;1
GO:0005545;1-phosphatidylinositol binding;1/135;15/18368;1,04788758170708e-01;0,272688927512410251;0,221234638960884411;PICALM;1
GO:0008559;ABC-type xenobiotic transporter activity;1/135;15/18368;1,04788758170708e-01;0,272688927512410251;0,221234638960884411;ABCG2;1
GO:0042043;neurexin family protein binding;1/135;15/18368;1,04788758170708e-01;0,272688927512410251;0,221234638960884411;CEL;1
GO:0051371;muscle alpha-actinin binding;1/135;15/18368;1,04788758170708e-01;0,272688927512410251;0,221234638960884411;PKD2;1
GO:0022836;gated channel activity;5/135;340/18368;1,06049552533775e-01;0,274410706556321937;0,222631531634984225;GRID2/ITPR1/KCNK16/PKD2/SCN3A;5
GO:0038024;cargo receptor activity;2/135;77/18368;1,09998195603798e-01;0,275525718664968167;0,223536149594883410;LRP10/SCARF2;2
GO:0005402;carbohydrate:cation symporter activity;1/135;16/18368;1,11373704372797e-01;0,275525718664968167;0,223536149594883410;SLC45A3;1
GO:0050135;"NAD(P)+ nucleosidase activity";1/135;16/18368;1,11373704372797e-01;0,275525718664968167;0,223536149594883410;BST1;1
GO:0061809;"NAD+ nucleotidase, cyclic ADP-ribose generating";1/135;16/18368;1,11373704372797e-01;0,275525718664968167;0,223536149594883410;BST1;1
GO:0140327;flippase activity;1/135;16/18368;1,11373704372797e-01;0,275525718664968167;0,223536149594883410;ATP10B;1
GO:0008083;growth factor activity;3/135;162/18368;1,17065167881573e-01;0,275525718664968167;0,223536149594883410;GH2/GRN/OGN;3
GO:0004527;exonuclease activity;2/135;80/18368;1,17159337448232e-01;0,275525718664968167;0,223536149594883410;DIS3/POLG;2
GO:0003951;"NAD+ kinase activity";1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;DGKQ;1
GO:0004659;prenyltransferase activity;1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;NUS1;1
GO:0005001;transmembrane receptor protein tyrosine phosphatase activity;1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;PTPRH;1
GO:0008525;phosphatidylcholine transporter activity;1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;ATP10B;1
GO:0016290;palmitoyl-CoA hydrolase activity;1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;PLA2G6;1
GO:0016722;oxidoreductase activity, acting on metal ions;1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;CP;1
GO:0019198;transmembrane receptor protein phosphatase activity;1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;PTPRH;1
GO:0031489;myosin V binding;1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;RAB39B;1
GO:0043395;heparan sulfate proteoglycan binding;1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;APOE;1
GO:0050780;dopamine receptor binding;1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;VPS35;1
GO:0070064;proline-rich region binding;1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;GIGYF2;1
GO:0070628;proteasome binding;1/135;17/18368;1,17910569559681e-01;0,275525718664968167;0,223536149594883410;WFS1;1
GO:0019787;ubiquitin-like protein transferase activity;6/135;458/18368;1,21878905050903e-01;0,283352987377227139;0,229886473326042701;FBXO7/HERC3/HERC5/HERC6/PRKN/RFPL2;6
GO:0008569;minus-end-directed microtubule motor activity;1/135;18/18368;1,24399702201468e-01;0,283458027901853260;0,229971693517247000;DNAH8;1
GO:0030228;lipoprotein particle receptor activity;1/135;18/18368;1,24399702201468e-01;0,283458027901853260;0,229971693517247000;LRP10;1
GO:0046624;sphingolipid transporter activity;1/135;18/18368;1,24399702201468e-01;0,283458027901853260;0,229971693517247000;ATP10B;1
GO:0140597;protein carrier activity;1/135;18/18368;1,24399702201468e-01;0,283458027901853260;0,229971693517247000;CLU;1
GO:0008013;beta-catenin binding;2/135;85/18368;1,29344607683361e-01;0,290899918950471625;0,236009357365011496;PRKN/PSEN1;2
GO:0004653;polypeptide N-acetylgalactosaminyltransferase activity;1/135;19/18368;1,30841448261566e-01;0,290899918950471625;0,236009357365011496;GALNT3;1
GO:0004745;"NAD-retinol dehydrogenase activity";1/135;19/18368;1,30841448261566e-01;0,290899918950471625;0,236009357365011496;ADH1C;1
GO:0004970;ionotropic glutamate receptor activity;1/135;19/18368;1,30841448261566e-01;0,290899918950471625;0,236009357365011496;GRID2;1
GO:0005326;neurotransmitter transmembrane transporter activity;1/135;19/18368;1,30841448261566e-01;0,290899918950471625;0,236009357365011496;SLC6A3;1
GO:0016209;antioxidant activity;2/135;86/18368;1,31816403702105e-01;0,291651753118667867;0,236619326248884737;APOE/PARK7;2
GO:0004252;serine-type endopeptidase activity;3/135;174/18368;1,36644741498149e-01;0,293711015216232108;0,238290021538335839;HTRA2/LPA/PRSS48;3
GO:0008276;protein methyltransferase activity;2/135;88/18368;1,36792364405607e-01;0,293711015216232108;0,238290021538335839;PRDM2/PRMT3;2
GO:0051219;phosphoprotein binding;2/135;88/18368;1,36792364405607e-01;0,293711015216232108;0,238290021538335839;PKD2/SNCA;2
GO:0030296;protein tyrosine kinase activator activity;1/135;20/18368;1,37236151214571e-01;0,293711015216232108;0,238290021538335839;DGKQ;1
GO:0031683;G-protein beta/gamma-subunit complex binding;1/135;20/18368;1,37236151214571e-01;0,293711015216232108;0,238290021538335839;ADORA1;1
GO:0031690;adrenergic receptor binding;1/135;20/18368;1,37236151214571e-01;0,293711015216232108;0,238290021538335839;UCHL1;1
GO:0070300;phosphatidic acid binding;1/135;20/18368;1,37236151214571e-01;0,293711015216232108;0,238290021538335839;ATP13A2;1
GO:0043178;alcohol binding;2/135;89/18368;1,39295952286729e-01;0,296732772778241172;0,240741596852951295;GRAMD1C/ITPR1;2
GO:0001848;complement binding;1/135;21/18368;1,43584152064039e-01;0,298916098387862983;0,242512945830649529;CR1;1
GO:0005385;zinc ion transmembrane transporter activity;1/135;21/18368;1,43584152064039e-01;0,298916098387862983;0,242512945830649529;SLC30A10;1
GO:0015662;P-type ion transporter activity;1/135;21/18368;1,43584152064039e-01;0,298916098387862983;0,242512945830649529;ATP1A3;1
GO:0051010;microtubule plus-end binding;1/135;21/18368;1,43584152064039e-01;0,298916098387862983;0,242512945830649529;DCTN1;1
GO:0140358;P-type transmembrane transporter activity;1/135;21/18368;1,43584152064039e-01;0,298916098387862983;0,242512945830649529;ATP1A3;1
GO:0004866;endopeptidase inhibitor activity;3/135;180/18368;1,46830798659616e-01;0,302710483603969904;0,245591359945303067;LPA/PZP/SNCA;3
GO:0009975;cyclase activity;1/135;22/18368;1,49885789360129e-01;0,302710483603969904;0,245591359945303067;BST1;1
GO:0017075;syntaxin-1 binding;1/135;22/18368;1,49885789360129e-01;0,302710483603969904;0,245591359945303067;LRRK2;1
GO:0030021;extracellular matrix structural constituent conferring compression resistance;1/135;22/18368;1,49885789360129e-01;0,302710483603969904;0,245591359945303067;OGN;1
GO:0030742;GTP-dependent protein binding;1/135;22/18368;1,49885789360129e-01;0,302710483603969904;0,245591359945303067;GCH1;1
GO:0043027;cysteine-type endopeptidase inhibitor activity involved in apoptotic process;1/135;22/18368;1,49885789360129e-01;0,302710483603969904;0,245591359945303067;SNCA;1
GO:0030695;GTPase regulator activity;6/135;488/18368;1,50694301881452e-01;0,302710483603969904;0,245591359945303067;DIS3/FAM13A/KALRN/LRRK2/TBC1D24/TNK2;6
GO:0060589;nucleoside-triphosphatase regulator activity;6/135;488/18368;1,50694301881452e-01;0,302710483603969904;0,245591359945303067;DIS3/FAM13A/KALRN/LRRK2/TBC1D24/TNK2;6
GO:0004674;protein serine/threonine kinase activity;5/135;386/18368;1,55469425762179e-01;0,308244658799315785;0,250081279145388358;GAK/KALRN/LRRK2/MAP3K6/PINK1;5
GO:0016849;phosphorus-oxygen lyase activity;1/135;23/18368;1,56141399217121e-01;0,308244658799315785;0,250081279145388358;BST1;1
GO:0030215;semaphorin receptor binding;1/135;23/18368;1,56141399217121e-01;0,308244658799315785;0,250081279145388358;RIT2;1
GO:0047617;acyl-CoA hydrolase activity;1/135;23/18368;1,56141399217121e-01;0,308244658799315785;0,250081279145388358;PLA2G6;1
GO:0030546;signaling receptor activator activity;6/135;495/18368;1,57828845792213e-01;0,310238675419886811;0,251699040274006081;DGKQ/GH2/GRN/OGN/POMC/SPP1;6
GO:0030414;peptidase inhibitor activity;3/135;187/18368;1,59017354410295e-01;0,311239095384253150;0,252510688739695122;LPA/PZP/SNCA;3
GO:0004622;lysophospholipase activity;1/135;24/18368;1,62351315330813e-01;0,312423959754254299;0,253471978380261476;PLA2G6;1
GO:0008171;O-methyltransferase activity;1/135;24/18368;1,62351315330813e-01;0,312423959754254299;0,253471978380261476;COMT;1
GO:0010857;calcium-dependent protein kinase activity;1/135;24/18368;1,62351315330813e-01;0,312423959754254299;0,253471978380261476;PINK1;1
GO:0070840;dynein complex binding;1/135;24/18368;1,62351315330813e-01;0,312423959754254299;0,253471978380261476;SNCA;1
GO:0140297;DNA-binding transcription factor binding;5/135;394/18368;1,64912302009635e-01;0,316024411382481163;0,256393052672985122;CHCHD2/DGKQ/PARK7/WFS1/ZNF516;5
GO:0008236;serine-type peptidase activity;3/135;191/18368;1,66117328178467e-01;0,316312573770787531;0,256626841050535515;HTRA2/LPA/PRSS48;3
GO:0005496;steroid binding;2/135;100/18368;1,67437393828624e-01;0,316312573770787531;0,256626841050535515;ATP1A3/GRAMD1C;2
GO:0003887;DNA-directed DNA polymerase activity;1/135;25/18368;1,68515868995791e-01;0,316312573770787531;0,256626841050535515;POLG;1
GO:0016289;CoA hydrolase activity;1/135;25/18368;1,68515868995791e-01;0,316312573770787531;0,256626841050535515;PLA2G6;1
GO:0051019;mitogen-activated protein kinase binding;1/135;25/18368;1,68515868995791e-01;0,316312573770787531;0,256626841050535515;GCH1;1
GO:0061135;endopeptidase regulator activity;3/135;194/18368;1,71503341408413e-01;0,320493533125374208;0,260018885757888063;LPA/PZP/SNCA;3
GO:0033218;amide binding;5/135;400/18368;1,72142814735463e-01;0,320493533125374208;0,260018885757888063;APOE/ATP1A3/CLU/MCCC1/PICALM;5
GO:0097602;cullin family protein binding;1/135;26/18368;1,74635389122573e-01;0,323817847036997342;0,262715927382349057;PRKN;1
GO:0008066;glutamate receptor activity;1/135;27/18368;1,80710202254644e-01;0,328433621558043787;0,266460741002044255;GRID2;1
GO:0035255;ionotropic glutamate receptor binding;1/135;27/18368;1,80710202254644e-01;0,328433621558043787;0,266460741002044255;PTEN;1
GO:0051393;alpha-actinin binding;1/135;27/18368;1,80710202254644e-01;0,328433621558043787;0,266460741002044255;PKD2;1
GO:0051959;dynein light intermediate chain binding;1/135;27/18368;1,80710202254644e-01;0,328433621558043787;0,266460741002044255;DNAH8;1
GO:0140326;ATPase-coupled intramembrane lipid transporter activity;1/135;27/18368;1,80710202254644e-01;0,328433621558043787;0,266460741002044255;ATP10B;1
GO:0005244;voltage-gated ion channel activity;3/135;201/18368;1,84260977628640e-01;0,330220886965613580;0,267910763270194363;KCNK16/PKD2/SCN3A;3
GO:0005516;calmodulin binding;3/135;201/18368;1,84260977628640e-01;0,330220886965613580;0,267910763270194363;PLA2G6/RIT2/WFS1;3
GO:0022832;voltage-gated channel activity;3/135;201/18368;1,84260977628640e-01;0,330220886965613580;0,267910763270194363;KCNK16/PKD2/SCN3A;3
GO:0001968;fibronectin binding;1/135;28/18368;1,86740632585358e-01;0,330220886965613580;0,267910763270194363;LPA;1
GO:0003953;"NAD+ nucleosidase activity";1/135;28/18368;1,86740632585358e-01;0,330220886965613580;0,267910763270194363;BST1;1
GO:0050681;androgen receptor binding;1/135;28/18368;1,86740632585358e-01;0,330220886965613580;0,267910763270194363;PARK7;1
GO:1990756;ubiquitin ligase-substrate adaptor activity;1/135;28/18368;1,86740632585358e-01;0,330220886965613580;0,267910763270194363;FBXO7;1
GO:0051787;misfolded protein binding;1/135;29/18368;1,92727001974724e-01;0,338748327727336540;0,274829142008158556;CLU;1
GO:0008047;enzyme activator activity;2/135;110/18368;1,93781794464110e-01;0,338748327727336540;0,274829142008158556;APOE/PARK7;2
GO:0047485;protein N-terminus binding;2/135;110/18368;1,93781794464110e-01;0,338748327727336540;0,274829142008158556;SLC6A3/SNCA;2
GO:0008094;ATP-dependent activity, acting on DNA;2/135;111/18368;1,96446560084085e-01;0,342100853682550665;0,277549072282096965;SMARCAD1/TWNK;2
GO:0008509;anion transmembrane transporter activity;4/135;314/18368;2,00479507254650e-01;0,347801569403901112;0,282174107100843674;ABCG2/GET3/SLC18A2/SLC6A3;4
GO:0099094;ligand-gated cation channel activity;2/135;113/18368;2,01789789808574e-01;0,348753674461610930;0,282946557308546676;ITPR1/PKD2;2
GO:0003774;cytoskeletal motor activity;2/135;114/18368;2,04467836625767e-01;0,349598977170153868;0,283632357943149394;DNAH8/KIF21A;2
GO:0042910;xenobiotic transmembrane transporter activity;1/135;31/18368;2,04568833802623e-01;0,349598977170153868;0,283632357943149394;ABCG2;1
GO:0090482;vitamin transmembrane transporter activity;1/135;31/18368;2,04568833802623e-01;0,349598977170153868;0,283632357943149394;ABCG2;1
GO:0008168;methyltransferase activity;3/135;214/18368;2,08581288950191e-01;0,352896395393935414;0,286307578887748104;COMT/PRDM2/PRMT3;3
GO:0030332;cyclin binding;1/135;32/18368;2,10424928443875e-01;0,352896395393935414;0,286307578887748104;GAK;1
GO:0031624;ubiquitin conjugating enzyme binding;1/135;32/18368;2,10424928443875e-01;0,352896395393935414;0,286307578887748104;PRKN;1
GO:0050699;WW domain binding;1/135;32/18368;2,10424928443875e-01;0,352896395393935414;0,286307578887748104;TNK2;1
GO:0140658;ATP-dependent chromatin remodeler activity;1/135;32/18368;2,10424928443875e-01;0,352896395393935414;0,286307578887748104;SMARCAD1;1
GO:0042277;peptide binding;4/135;321/18368;2,11121424318643e-01;0,352896395393935414;0,286307578887748104;APOE/ATP1A3/CLU/PICALM;4
GO:0004623;phospholipase A2 activity;1/135;33/18368;2,16238226581968e-01;0,356248589117055592;0,289027239619215393;PLA2G6;1
GO:0005154;epidermal growth factor receptor binding;1/135;33/18368;2,16238226581968e-01;0,356248589117055592;0,289027239619215393;TNK2;1
GO:0008200;ion channel inhibitor activity;1/135;33/18368;2,16238226581968e-01;0,356248589117055592;0,289027239619215393;ITPR1;1
GO:0051427;hormone receptor binding;1/135;33/18368;2,16238226581968e-01;0,356248589117055592;0,289027239619215393;GH2;1
GO:0004993;G protein-coupled serotonin receptor activity;1/135;34/18368;2,22009038657858e-01;0,358028660934150644;0,290471425671696482;DRD4;1
GO:0008376;acetylgalactosaminyltransferase activity;1/135;34/18368;2,22009038657858e-01;0,358028660934150644;0,290471425671696482;GALNT3;1
GO:0016248;channel inhibitor activity;1/135;34/18368;2,22009038657858e-01;0,358028660934150644;0,290471425671696482;ITPR1;1
GO:0043548;phosphatidylinositol 3-kinase binding;1/135;34/18368;2,22009038657858e-01;0,358028660934150644;0,290471425671696482;FAM83A;1
GO:0045505;dynein intermediate chain binding;1/135;34/18368;2,22009038657858e-01;0,358028660934150644;0,290471425671696482;DNAH8;1
GO:0099589;serotonin receptor activity;1/135;34/18368;2,22009038657858e-01;0,358028660934150644;0,290471425671696482;DRD4;1
GO:0005179;hormone activity;2/135;122/18368;2,26020120406998e-01;0,362296931748175177;0,293934306842348503;GH2/POMC;2
GO:0000175;3'-5'-exoribonuclease activity;1/135;35/18368;2,27737672877406e-01;0,362296931748175177;0,293934306842348503;DIS3;1
GO:0042887;amide transmembrane transporter activity;1/135;35/18368;2,27737672877406e-01;0,362296931748175177;0,293934306842348503;ABCG2;1
GO:0003697;single-stranded DNA binding;2/135;123/18368;2,28727257760994e-01;0,362296931748175177;0,293934306842348503;MAPT/TWNK;2
GO:0016741;transferase activity, transferring one-carbon groups;3/135;225/18368;2,29691494618303e-01;0,362296931748175177;0,293934306842348503;COMT/PRDM2/PRMT3;3
GO:0140101;catalytic activity, acting on a tRNA;2/135;124/18368;2,31436688876609e-01;0,362296931748175177;0,293934306842348503;DARS1/PTRHD1;2
GO:0000217;DNA secondary structure binding;1/135;36/18368;2,33424435227351e-01;0,362296931748175177;0,293934306842348503;MAPT;1
GO:0016814;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines;1/135;36/18368;2,33424435227351e-01;0,362296931748175177;0,293934306842348503;GCH1;1
GO:0034061;DNA polymerase activity;1/135;36/18368;2,33424435227351e-01;0,362296931748175177;0,293934306842348503;POLG;1
GO:0042805;actinin binding;1/135;36/18368;2,33424435227351e-01;0,362296931748175177;0,293934306842348503;PKD2;1
GO:0043394;proteoglycan binding;1/135;36/18368;2,33424435227351e-01;0,362296931748175177;0,293934306842348503;APOE;1
GO:0016810;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds;2/135;125/18368;2,34148235365633e-01;0,362296931748175177;0,293934306842348503;DARS1/GCH1;2
GO:0003924;GTPase activity;4/135;337/18368;2,36017567410895e-01;0,363959750418148098;0,295283364508403312;GCH1/LRRK2/RAB39B/RIT2;4
GO:0140097;catalytic activity, acting on DNA;3/135;229/18368;2,37467668377234e-01;0,364967087640178101;0,296100624998811512;POLG/SMARCAD1/TWNK;3
GO:0046915;transition metal ion transmembrane transporter activity;1/135;37/18368;2,39069629491169e-01;0,364979634356517924;0,296110804246956627;SLC30A10;1
GO:0071855;neuropeptide receptor binding;1/135;37/18368;2,39069629491169e-01;0,364979634356517924;0,296110804246956627;POMC;1
GO:0140678;molecular function inhibitor activity;2/135;128/18368;2,42293819942656e-01;0,368672988484174458;0,299107251057029566;ITPR1/LRRK2;2
GO:0016896;exoribonuclease activity, producing 5'-phosphomonoesters;1/135;38/18368;2,44673557264814e-01;0,369836598109850700;0,300051296558899783;DIS3;1
GO:0140303;intramembrane lipid transporter activity;1/135;38/18368;2,44673557264814e-01;0,369836598109850700;0,300051296558899783;ATP10B;1
GO:0005096;GTPase activator activity;5/135;462/18368;2,53110413370703e-01;0,378065931006585143;0,306727818077050185;DIS3/FAM13A/KALRN/LRRK2/TBC1D24;5
GO:0003925;G protein activity;1/135;40/18368;2,55758808881502e-01;0,378065931006585143;0,306727818077050185;RIT2;1
GO:0004532;exoribonuclease activity;1/135;40/18368;2,55758808881502e-01;0,378065931006585143;0,306727818077050185;DIS3;1
GO:0043014;alpha-tubulin binding;1/135;40/18368;2,55758808881502e-01;0,378065931006585143;0,306727818077050185;SNCA;1
GO:0043028;cysteine-type endopeptidase regulator activity involved in apoptotic process;1/135;40/18368;2,55758808881502e-01;0,378065931006585143;0,306727818077050185;SNCA;1
GO:0044183;protein folding chaperone;1/135;40/18368;2,55758808881502e-01;0,378065931006585143;0,306727818077050185;RIC3;1
GO:0044325;transmembrane transporter binding;2/135;133/18368;2,55896154174763e-01;0,378065931006585143;0,306727818077050185;LRRK2/PKD2;2
GO:0004812;aminoacyl-tRNA ligase activity;1/135;41/18368;2,61240725119008e-01;0,383487987514440520;0,311126774517576421;DARS1;1
GO:0016875;ligase activity, forming carbon-oxygen bonds;1/135;41/18368;2,61240725119008e-01;0,383487987514440520;0,311126774517576421;DARS1;1
GO:0016614;oxidoreductase activity, acting on CH-OH group of donors;2/135;136/18368;2,64066253878696e-01;0,386397266058922551;0,313487094734083316;ADH1C/L2HGDH;2
GO:0019894;kinesin binding;1/135;42/18368;2,66682559685982e-01;0,388982841834967008;0,315584792387366919;SNCA;1
GO:0005246;calcium channel regulator activity;1/135;43/18368;2,72084603473081e-01;0,390861795409970847;0,317109201975912913;ITPR1;1
GO:0016504;peptidase activator activity;1/135;43/18368;2,72084603473081e-01;0,390861795409970847;0,317109201975912913;PINK1;1
GO:0016790;thiolester hydrolase activity;1/135;43/18368;2,72084603473081e-01;0,390861795409970847;0,317109201975912913;PLA2G6;1
GO:0032266;phosphatidylinositol-3-phosphate binding;1/135;43/18368;2,72084603473081e-01;0,390861795409970847;0,317109201975912913;WDR45;1
GO:0099106;ion channel regulator activity;2/135;139/18368;2,72237800733146e-01;0,390861795409970847;0,317109201975912913;DRD4/ITPR1;2
GO:0004712;protein serine/threonine/tyrosine kinase activity;1/135;44/18368;2,77447145275599e-01;0,393408026427938984;0,319174978922230401;TNK2;1
GO:0008375;acetylglucosaminyltransferase activity;1/135;44/18368;2,77447145275599e-01;0,393408026427938984;0,319174978922230401;PIGY;1
GO:0051879;Hsp90 protein binding;1/135;44/18368;2,77447145275599e-01;0,393408026427938984;0,319174978922230401;MAPT;1
GO:1904315;transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;1/135;44/18368;2,77447145275599e-01;0,393408026427938984;0,319174978922230401;GRID2;1
GO:0004715;non-membrane spanning protein tyrosine kinase activity;1/135;45/18368;2,82770471808441e-01;0,397769694599872381;0,322713634092748558;TNK2;1
GO:0005245;voltage-gated calcium channel activity;1/135;45/18368;2,82770471808441e-01;0,397769694599872381;0,322713634092748558;PKD2;1
GO:0008194;UDP-glycosyltransferase activity;2/135;143/18368;2,83128647247944e-01;0,397769694599872381;0,322713634092748558;GALNT3/PIGY;2
GO:0016798;hydrolase activity, acting on glycosyl bonds;2/135;144/18368;2,85849613416129e-01;0,399289672751441671;0,323946804139873312;BST1/SMPD1;2
GO:0060090;molecular adaptor activity;4/135;369/18368;2,87655763424925e-01;0,399289672751441671;0,323946804139873312;EIF4G1/FBXO7/LRRK2/MAPT;4
GO:0004864;protein phosphatase inhibitor activity;1/135;46/18368;2,88054867721002e-01;0,399289672751441671;0,323946804139873312;CABIN1;1
GO:0048018;receptor ligand activity;5/135;487/18368;2,88194240119711e-01;0,399289672751441671;0,323946804139873312;GH2/GRN/OGN/POMC/SPP1;5
GO:0016247;channel regulator activity;2/135;145/18368;2,88569610656610e-01;0,399289672751441671;0,323946804139873312;DRD4/ITPR1;2
GO:0005044;scavenger receptor activity;1/135;47/18368;2,93300615611935e-01;0,400990095373928379;0,325326370183858238;SCARF2;1
GO:0008138;protein tyrosine/serine/threonine phosphatase activity;1/135;47/18368;2,93300615611935e-01;0,400990095373928379;0,325326370183858238;PTEN;1
GO:0035254;glutamate receptor binding;1/135;47/18368;2,93300615611935e-01;0,400990095373928379;0,325326370183858238;PTEN;1
GO:0099529;neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential;1/135;47/18368;2,93300615611935e-01;0,400990095373928379;0,325326370183858238;GRID2;1
GO:0005525;GTP binding;4/135;377/18368;3,00837983231329e-01;0,409422887782019074;0,332167959979436267;GCH1/LRRK2/RAB39B/RIT2;4
GO:0019903;protein phosphatase binding;2/135;150/18368;3,02150515437385e-01;0,409422887782019074;0,332167959979436267;MAPT/SLC6A3;2
GO:0140677;molecular function activator activity;2/135;150/18368;3,02150515437385e-01;0,409422887782019074;0,332167959979436267;APOE/PARK7;2
GO:0019212;phosphatase inhibitor activity;1/135;49/18368;3,03677287557679e-01;0,410277869325714195;0,332861613127963918;CABIN1;1
GO:0005506;iron ion binding;2/135;151/18368;3,04861997599565e-01;0,410667043825296729;0,333177353413766364;SNCA/TH;2
GO:0015485;cholesterol binding;1/135;50/18368;3,08808766687529e-01;0,412345233652734899;0,334538881818927603;GRAMD1C;1
GO:0016799;hydrolase activity, hydrolyzing N-glycosyl compounds;1/135;50/18368;3,08808766687529e-01;0,412345233652734899;0,334538881818927603;BST1;1
GO:0030159;signaling receptor complex adaptor activity;1/135;50/18368;3,08808766687529e-01;0,412345233652734899;0,334538881818927603;LRRK2;1
GO:0003743;translation initiation factor activity;1/135;51/18368;3,13902707974633e-01;0,415512833099370205;0,337108779784136170;EIF4G1;1
GO:0008227;G protein-coupled amine receptor activity;1/135;51/18368;3,13902707974633e-01;0,415512833099370205;0,337108779784136170;DRD4;1
GO:0051018;protein kinase A binding;1/135;51/18368;3,13902707974633e-01;0,415512833099370205;0,337108779784136170;LRRK2;1
GO:0004386;helicase activity;2/135;156/18368;3,18389289626071e-01;0,416192016705607570;0,337659806704388610;SMARCAD1/TWNK;2
GO:0008757;S-adenosylmethionine-dependent methyltransferase activity;2/135;156/18368;3,18389289626071e-01;0,416192016705607570;0,337659806704388610;COMT/PRMT3;2
GO:0004879;nuclear receptor activity;1/135;52/18368;3,18959383981808e-01;0,416192016705607570;0,337659806704388610;SREBF1;1
GO:0098531;ligand-activated transcription factor activity;1/135;52/18368;3,18959383981808e-01;0,416192016705607570;0,337659806704388610;SREBF1;1
GO:1901682;sulfur compound transmembrane transporter activity;1/135;52/18368;3,18959383981808e-01;0,416192016705607570;0,337659806704388610;ABCG2;1
GO:1901505;carbohydrate derivative transmembrane transporter activity;1/135;53/18368;3,23979065307559e-01;0,421540942928585738;0,341999431978374568;SLC50A1;1
GO:0015459;potassium channel regulator activity;1/135;54/18368;3,28962020600133e-01;0,426811913413203181;0,346275811158034297;DRD4;1
GO:0016684;oxidoreductase activity, acting on peroxide as acceptor;1/135;55/18368;3,33908516571465e-01;0,431933778164916793;0,350431219701713703;PARK7;1
GO:0019001;guanyl nucleotide binding;4/135;398/18368;3,35738919272293e-01;0,431933778164916793;0,350431219701713703;GCH1/LRRK2/RAB39B/RIT2;4
GO:0032561;guanyl ribonucleotide binding;4/135;398/18368;3,35738919272293e-01;0,431933778164916793;0,350431219701713703;GCH1/LRRK2/RAB39B/RIT2;4
GO:0004869;cysteine-type endopeptidase inhibitor activity;1/135;56/18368;3,38818818011035e-01;0,432253533841376658;0,350690639958643857;SNCA;1
GO:0042054;histone methyltransferase activity;1/135;56/18368;3,38818818011035e-01;0,432253533841376658;0,350690639958643857;PRDM2;1
GO:0050840;extracellular matrix binding;1/135;56/18368;3,38818818011035e-01;0,432253533841376658;0,350690639958643857;SPP1;1
GO:0005548;phospholipid transporter activity;1/135;57/18368;3,43693187799617e-01;0,437254111145068569;0,354747647056329996;ATP10B;1
GO:0008028;monocarboxylic acid transmembrane transporter activity;1/135;58/18368;3,48531886922934e-01;0,440960232626253557;0,357754452119208199;ABCG2;1
GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;1/135;58/18368;3,48531886922934e-01;0,440960232626253557;0,357754452119208199;NUS1;1
GO:0016796;exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters;1/135;59/18368;3,53335174485217e-01;0,444581071192937882;0,360692066493006336;DIS3;1
GO:0036002;pre-mRNA binding;1/135;59/18368;3,53335174485217e-01;0,444581071192937882;0,360692066493006336;TARDBP;1
GO:0022824;transmitter-gated ion channel activity;1/135;60/18368;3,58103307722668e-01;0,446897315904583314;0,362571253767680790;GRID2;1
GO:0022835;transmitter-gated channel activity;1/135;60/18368;3,58103307722668e-01;0,446897315904583314;0,362571253767680790;GRID2;1
GO:0032934;sterol binding;1/135;60/18368;3,58103307722668e-01;0,446897315904583314;0,362571253767680790;GRAMD1C;1
GO:0030674;protein-macromolecule adaptor activity;3/135;296/18368;3,71253507225009e-01;0,461431703883035393;0,374363115308461170;FBXO7/LRRK2/MAPT;3
GO:0031406;carboxylic acid binding;2/135;176/18368;3,71764844394847e-01;0,461431703883035393;0,374363115308461170;CPS1/MCCC1;2
GO:0016836;hydro-lyase activity;1/135;64/18368;3,76829377513011e-01;0,466453661894483673;0,378437468739951044;PARK7;1
GO:0043022;ribosome binding;1/135;66/18368;3,85988039529922e-01;0,476502754999202915;0,386590375809511833;PRMT3;1
GO:0004857;enzyme inhibitor activity;1/135;70/18368;4,03906435031232e-01;0,495949456419046808;0,402367635292860293;LRRK2;1
GO:0004860;protein kinase inhibitor activity;1/135;70/18368;4,03906435031232e-01;0,495949456419046808;0,402367635292860293;SNCA;1
GO:0003779;actin binding;4/135;441/18368;4,07471193617907e-01;0,497349419858451824;0,403503436474450639;LRRK2/MAPT/PRKN/SNCA;4
GO:0016811;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides;1/135;71/18368;4,08304327220039e-01;0,497349419858451824;0,403503436474450639;DARS1;1
GO:0031491;nucleosome binding;1/135;71/18368;4,08304327220039e-01;0,497349419858451824;0,403503436474450639;CABIN1;1
GO:0015453;oxidoreduction-driven active transmembrane transporter activity;1/135;72/18368;4,12670010983787e-01;0,501333859497544831;0,406736043214510012;UQCRC1;1
GO:0005230;extracellular ligand-gated ion channel activity;1/135;73/18368;4,17003720456742e-01;0,503925340288094548;0,408838531651798232;GRID2;1
GO:0033293;monocarboxylic acid binding;1/135;73/18368;4,17003720456742e-01;0,503925340288094548;0,408838531651798232;MCCC1;1
GO:0017022;myosin binding;1/135;74/18368;4,21305688083872e-01;0,505032017723205495;0,409736387626503162;RAB39B;1
GO:0019210;kinase inhibitor activity;1/135;74/18368;4,21305688083872e-01;0,505032017723205495;0,409736387626503162;SNCA;1
GO:0019905;syntaxin binding;1/135;74/18368;4,21305688083872e-01;0,505032017723205495;0,409736387626503162;LRRK2;1
GO:0016829;lyase activity;2/135;196/18368;4,23432958091072e-01;0,505032017723205495;0,409736387626503162;BST1/PARK7;2
GO:0019902;phosphatase binding;2/135;196/18368;4,23432958091072e-01;0,505032017723205495;0,409736387626503162;MAPT/SLC6A3;2
GO:0019003;GDP binding;1/135;75/18368;4,25576144632941e-01;0,505414982444117644;0,410047089870773429;RIT2;1
GO:0016758;hexosyltransferase activity;2/135;197/18368;4,25961098741112e-01;0,505414982444117644;0,410047089870773429;GALNT3/PIGY;2
GO:0001618;virus receptor activity;1/135;76/18368;4,29815319206524e-01;0,508670326089374902;0,412688175383933209;CR1;1
GO:0140272;exogenous protein binding;1/135;77/18368;4,34023439253929e-01;0,511491013784713955;0,414976621158363645;CR1;1
GO:0046982;protein heterodimerization activity;3/135;328/18368;4,34432323935052e-01;0,511491013784713955;0,414976621158363645;ADORA1/FBXO7/VAPB;3
GO:0016835;carbon-oxygen lyase activity;1/135;79/18368;4,42347417372063e-01;0,519474659375397385;0,421453814662181736;PARK7;1
GO:0019887;protein kinase regulator activity;2/135;204/18368;4,43495586071207e-01;0,519490993403101897;0,421467066585371086;DGKQ/SNCA;2
GO:0035591;signaling adaptor activity;1/135;81/18368;4,50549865964337e-01;0,526407751560372894;0,427078686051049483;LRRK2;1
GO:0005546;phosphatidylinositol-4,5-bisphosphate binding;1/135;82/18368;4,54606068080310e-01;0,529795366872219176;0,429827084591802688;PICALM;1
GO:0004518;nuclease activity;2/135;210/18368;4,58289969326008e-01;0,532733010028709542;0,432210417237725630;DIS3/POLG;2
GO:0008135;translation factor activity, RNA binding;1/135;84/18368;4,62629516840486e-01;0,536415996741626988;0,435198452883921671;EIF4G1;1
GO:0042562;hormone binding;1/135;86/18368;4,70535791867256e-01;0,544205537058594202;0,441518167275761320;ATP1A3;1
GO:0048306;calcium-dependent protein binding;1/135;88/18368;4,78326591770604e-01;0,551822617206389032;0,447697963396587795;WFS1;1
GO:0008081;phosphoric diester hydrolase activity;1/135;89/18368;4,82179212673830e-01;0,552095198511534879;0,447919110720689018;SMPD1;1
GO:0015297;antiporter activity;1/135;89/18368;4,82179212673830e-01;0,552095198511534879;0,447919110720689018;ATP1A3;1
GO:0019888;protein phosphatase regulator activity;1/135;89/18368;4,82179212673830e-01;0,552095198511534879;0,447919110720689018;CABIN1;1
GO:0005249;voltage-gated potassium channel activity;1/135;90/18368;4,86003590719075e-01;0,555086395384878251;0,450345891911886953;PKD2;1
GO:0005085;guanyl-nucleotide exchange factor activity;2/135;223/18368;4,89554792932862e-01;0,557751480505599306;0,452508096112334057;DIS3/KALRN;2
GO:0072341;modified amino acid binding;1/135;93/18368;4,97309315390039e-01;0,565180313768331999;0,458535166077272294;CPS1;1
GO:0008170;N-methyltransferase activity;1/135;97/18368;5,12000514120113e-01;0,579942880011647732;0,470512150411656283;PRMT3;1
GO:0019207;kinase regulator activity;2/135;233/18368;5,12831586036501e-01;0,579942880011647732;0,470512150411656283;DGKQ/SNCA;2
GO:0004867;serine-type endopeptidase inhibitor activity;1/135;98/18368;5,15606224294367e-01;0,581644459918275847;0,471892655369228531;PZP;1
GO:0005125;cytokine activity;2/135;235/18368;5,17403510553514e-01;0,582237857084790256;0,472374083086487928;GRN/SPP1;2
GO:0030295;protein kinase activator activity;1/135;101/18368;5,26265448607532e-01;0,590758763387867036;0,479287160367540932;DGKQ;1
GO:0004497;monooxygenase activity;1/135;102/18368;5,29766525108216e-01;0,593234886306999276;0,481296058070261379;TH;1
GO:0031490;chromatin DNA binding;1/135;103/18368;5,33241917592087e-01;0,595670239651648004;0,483271879101428936;ATOH1;1
GO:0042393;histone binding;2/135;244/18368;5,37625585498335e-01;0,599105883596684818;0,486059243644288042;"NAP1L5/SNCA";2
GO:1990782;protein tyrosine kinase binding;1/135;105/18368;5,40116397249528e-01;0,600420655194863095;0,487125928025250898;PTEN;1
GO:0140098;catalytic activity, acting on RNA;3/135;386/18368;5,42134088131918e-01;0,601204388291569747;0,487761776756892806;DARS1/DIS3/PTRHD1;3
GO:0019208;phosphatase regulator activity;1/135;107/18368;5,46890367601457e-01;0,603556116533656373;0,489669752094646471;CABIN1;1
GO:0019209;kinase activator activity;1/135;107/18368;5,46890367601457e-01;0,603556116533656373;0,489669752094646471;DGKQ;1
GO:0090079;translation regulator activity, nucleic acid binding;1/135;108/18368;5,50240118457040e-01;0,605793207339722528;0,491484721192649965;EIF4G1;1
GO:0004222;metalloendopeptidase activity;1/135;111/18368;5,60142594188833e-01;0,615216566279341404;0,499129965287537281;SPG7;1
GO:0031267;small GTPase binding;2/135;259/18368;5,70026241007285e-01;0,624574206653915720;0,506721891401590963;LRRK2/PICALM;2
GO:0004540;ribonuclease activity;1/135;116/18368;5,76168053530311e-01;0,629797060899480399;0,510959233503830323;DIS3;1
GO:0005549;odorant binding;1/135;119/18368;5,85503727450906e-01;0,638477874220273689;0,518002044586891808;OR8B3;1
GO:0016757;glycosyltransferase activity;2/135;270/18368;5,92734554655542e-01;0,644827615278476207;0,523153638688352185;GALNT3/PIGY;2
GO:0004714;transmembrane receptor protein tyrosine kinase activity;1/135;124/18368;6,00611719815076e-01;0,650307725000720094;0,527599694151354104;TNK2;1
GO:0016616;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;1/135;124/18368;6,00611719815076e-01;0,650307725000720094;0,527599694151354104;ADH1C;1
GO:0009055;electron transfer activity;1/135;126/18368;6,06500713289685e-01;0,655135204449707298;0,531516265618815598;UQCRC1;1
GO:0042826;histone deacetylase binding;1/135;127/18368;6,09412806465099e-01;0,656731918496506695;0,532811692092086564;PRKN;1
GO:0004519;endonuclease activity;1/135;129/18368;6,15172971320459e-01;0,661383147569883145;0,536585270264694825;DIS3;1
GO:0016779;nucleotidyltransferase activity;1/135;132/18368;6,23655487783752e-01;0,668932584086554205;0,542710186583667209;POLG;1
GO:0051020;GTPase binding;2/135;291/18368;6,33596533388385e-01;0,677581071140586300;0,549726771116127222;LRRK2/PICALM;2
GO:0004713;protein tyrosine kinase activity;1/135;136/18368;6,34677466199370e-01;0,677581071140586300;0,549726771116127222;TNK2;1
GO:0019955;cytokine binding;1/135;139/18368;6,42733125454864e-01;0,684585515019366486;0,555409530686822195;PARK7;1
GO:0045182;translation regulator activity;1/135;140/18368;6,45378966042037e-01;0,685154879744235612;0,555871460698035280;EIF4G1;1
GO:0001228;DNA-binding transcription activator activity, RNA polymerase II-specific;3/135;450/18368;6,46259624562249e-01;0,685154879744235612;0,555871460698035280;ATOH1/PRDM2/SREBF1;3
GO:0019199;transmembrane receptor protein kinase activity;1/135;143/18368;6,53200351838768e-01;0,685709273431981403;0,556321244590874286;TNK2;1
GO:0022843;voltage-gated cation channel activity;1/135;143/18368;6,53200351838768e-01;0,685709273431981403;0,556321244590874286;PKD2;1
GO:0001216;DNA-binding transcription activator activity;3/135;456/18368;6,55123462406269e-01;0,685709273431981403;0,556321244590874286;ATOH1/PRDM2/SREBF1;3
GO:0005178;integrin binding;1/135;144/18368;6,55769238121444e-01;0,685709273431981403;0,556321244590874286;SPP1;1
GO:0016922;nuclear receptor binding;1/135;144/18368;6,55769238121444e-01;0,685709273431981403;0,556321244590874286;PARK7;1
GO:0140375;immune receptor activity;1/135;144/18368;6,55769238121444e-01;0,685709273431981403;0,556321244590874286;CR1;1
GO:0061630;ubiquitin protein ligase activity;2/135;304/18368;6,57262818857292e-01;0,685709273431981403;0,556321244590874286;HERC5/PRKN;2
GO:0019842;vitamin binding;1/135;148/18368;6,65857268167090e-01;0,693096883683016030;0,562314870007135426;MCCC1;1
GO:0043021;ribonucleoprotein complex binding;1/135;149/18368;6,68333078748727e-01;0,694096485412510567;0,563125854632535616;PRMT3;1
GO:0061659;ubiquitin-like protein ligase activity;2/135;316/18368;6,78019522871545e-01;0,702563216007166758;0,569994978741737102;HERC5/PRKN;2
GO:0046943;carboxylic acid transmembrane transporter activity;1/135;163/18368;7,01141623323415e-01;0,724882310343395231;0,588102632845825091;ABCG2;1
GO:0005342;organic acid transmembrane transporter activity;1/135;164/18368;7,03357821118050e-01;0,725535770432583438;0,588632790077457946;ABCG2;1
GO:0016705;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;1/135;170/18368;7,16316566578467e-01;0,737242668523455880;0,598130687172557907;TH;1
GO:0008514;organic anion transmembrane transporter activity;1/135;185/18368;7,46306958648338e-01;0,766386966504347344;0,621775681857123730;ABCG2;1
GO:0003714;transcription corepressor activity;1/135;187/18368;7,50060173838216e-01;0,768518030465107138;0,623504630554315820;PRKN;1
GO:0008022;protein C-terminus binding;1/135;189/18368;7,53758268033441e-01;0,770583229373473455;0,625180142424353269;SYNJ1;1
GO:0008237;metallopeptidase activity;1/135;190/18368;7,55586896330679e-01;0,770732290689200683;0,625301077024334240;SPG7;1
GO:0003730;mRNA 3'-UTR binding;1/135;201/18368;7,74833487711492e-01;0,788608305270807164;0,639804026110307844;TARDBP;1
GO:0003713;transcription coactivator activity;1/135;262/18368;8,57249650827115e-01;0,870555077780085895;0,706288077353183774;PARK7;1
GO:0005126;cytokine receptor binding;1/135;271/18368;8,66550102722370e-01;0,876114673392594745;0,710798620334603393;GH2;1
GO:0030246;carbohydrate binding;1/135;271/18368;8,66550102722370e-01;0,876114673392594745;0,710798620334603393;GALNT3;1
GO:0003712;transcription coregulator activity;2/135;489/18368;8,78082766147734e-01;0,885819178184278133;0,718671960236842433;PARK7/PRKN;2
GO:0061629;RNA polymerase II-specific DNA-binding transcription factor binding;1/135;299/18368;8,91807550296270e-01;0,897687600078443060;0,728300902844611353;PARK7;1
GO:0001227;DNA-binding transcription repressor activity, RNA polymerase II-specific;1/135;310/18368;9,00376792072408e-01;0,904325813090268826;0,733686536476361617;PRDM2;1
GO:0001217;DNA-binding transcription repressor activity;1/135;313/18368;9,02594574692398e-01;0,904569617525422531;0,733884336902951406;PRDM2;1
GO:0004984;olfactory receptor activity;1/135;430/18368;9,59636567725642e-01;0,959636567725641543;0,778560580112965805;OR8B3;1
